Auna S.A.

NYSE:AUNA

Medical - Care Facilities

Healthcare
$4.18 +1.47%

+$0.08 today

Market cap
$309.56M
Beta
0.81
P/E (TTM)
18.7
EPS (TTM)
$0.94
52W Low $4.09High $6.85

Volume 0.41M

Average 0.33M

AUNA EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Auna S.A.NYSE: AUNA

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA declines year over year

Q1 FY2026 EBITDA of PEN 192.19M fell 19.3% year over year, behind the -2.9% change in trailing-twelve-month EBITDA. Sequentially, it rose 372.8% from the prior quarter. Over 3 fiscal years it compounded at +42.0% a year.

Context

  • EBITDA amounted to 19.5% of revenue in FY2025, down 0.7 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 4 analysts of PEN 819.15M (-4.4%) for the fiscal year ending Dec 2026, a pace similar to FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
PEN 192.19M+372.8% QoQ
Last fiscal yearDec 2025
PEN 856.65M-3.4% YoY
LTMMar 2026
PEN 790.21M-2.9% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.3%-10.7%+8.6 pp
1 year-3.4%-4.4%-1.0 pp
3-year CAGR+42.0%+2.4%-39.6 pp
5-year CAGR+2.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

PEN · from the income statement

Latest · FY2025
856.65M PEN
Year-over-year change
-3.4%
4-year CAGR
+49.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How AUNA compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -2.9% is the 4th highest of 9, against a peer median of -29.1%.
  • EBITDA amounts to 17.5% of revenue for AUNA, versus a peer median of 6.3%.
AUNA Competitors
EBITDA for AUNA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 790.21M PEN-2.9%+42.0%17.5%
SNDASonida Senior Living, Inc.LTM Mar 2026$5M USD-88.2%+10.6%1.2%
KIDSOrthoPediatrics Corp.LTM Mar 2026-$6.63M USD+50.3%—2.7%
TOIThe Oncology Institute, Inc.LTM Mar 2026-$29.23M USD+37.4%—5.4%
TMCITreace Medical Concepts, Inc.LTM Mar 2026-$46.33M USD-19.5%—22.3%
CBLLCeriBell, Inc.LTM Mar 2026-$57.27M USD-38.6%—60.2%
CCRNCross Country Healthcare, Inc.LTM Mar 2026-$68.41M USD-902.3%—6.8%
AUTLAutolus Therapeutics plcLTM Mar 2026-$230.8M USD+3.4%—249.3%
AGLAgilon Health, Inc.LTM Mar 2026-$340.64M USD-53.6%—5.9%
Peer median (excluding AUNA) —-29.1%+10.6%6.3%

Competitors are the stored peer set for AUNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

PEN
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.92B2.45B3.88B4.39B4.39B
Cost of Revenue1.24B1.57B2.44B2.66B2.72B
Gross Profit686.94M879.7M1.44B1.73B1.66B
Gross Margin35.7%35.9%37.0%39.3%37.9%
Research & Development00000
Selling, General & Admin523.88M586.66M777.37M860.59M897.08M
Operating Expenses558.96M636.56M889.62M979.11M1.03B
Depreciation & Amortization77.4M138.09M235.75M219.15M222.43M
EBITDA170.15M299.14M647.3M887.03M856.65M
EBITDA Margin8.8%12.2%16.7%20.2%19.5%
Operating Income127.98M243.14M545.73M746.18M631.27M
Operating Margin6.7%9.9%14.1%17.0%14.4%
Interest Income1.75M6.88M(70.78M)(24.64M)18.92M
Interest Expense95.88M208.5M535.72M484.1M434.97M
Other Income / Expenses(131.1M)(290.59M)(669.91M)(562.41M)(432.02M)
Income Before Tax(3.13M)(47.45M)(124.17M)183.78M199.25M
Pre-Tax Margin-0.2%-1.9%-3.2%4.2%4.5%
Income Tax Expense19.9M29.38M90.17M59.82M88.35M
Net Income(26.47M)(85.61M)(253.92M)110.27M97.61M
Net Margin-1.4%-3.5%-6.6%2.5%2.2%
EPS (Basic)(0.55)(1.90)(5.78)1.643.06
EPS (Diluted)(0.55)(1.90)(5.78)1.633.06
Weighted Avg Shares47.92M45.04M43.92M67.65M30.1M
Weighted Avg Shares (Diluted)47.92M45.04M43.92M67.65M30.1M

Auna S.A.

NYSE:AUNA

Intrinsic Alpha fair value

Locked

Current Price

$4.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.